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Fibronectin (FN) polymorphism is caused by alternative splicing patterns in at least three regions of the primary tran- 
script of a single gene. Using a monoclonal antibody (Mab) specific for an FN segment (ED-A), that can be included 
or omitted from the molecule depending on the pattern of splicing, we have examined whether transforming growth factor 
B (TGF-8) and dexamethasone, which are both known to increase the level of total FN, regulate the levels of different 
FN isoforms. We found that, while dexamethasone does not significantly change the ratio between the total FN and 
the ED-A containing FN, TGF-8 preferentially increases the expression of the FN isoform containing the ED-A sequence. 
Transforming growth factor 8; Fibronectin isoform; RNA splicing 
1. INTRODUCTION 
Fibronectins (FNs) are high-molecular-mass 
adhesive glycoproteins present in soluble form in 
plasma and other body fluids and in insoluble 
form in the extracellular matrices. FN molecules 
are involved in diverse biological phenomena in- 
cluding the establishment of maintenance of nor- 
mal cell morphology, cell migration, hemostasis 
and thrombosis, wound healing, and oncogenic 
transformation [l-3]. 
It has previously been demonstrated that FN 
polymorphism is at least partially caused by alter- 
native splicing patterns in three regions of the 
primary transcript of a single gene (see fig.lA) 
[4-61. 
Recently it has been reported that dex- 
amethasone, a synthetic glucocorticoid, and 
human platelet-derived transforming growth fac- 
torfi (TGF-P) may increase levels of FN in both the 
media and the extracellular matrix of a variety of 
cultured cells [7,8]. TGF-,& are hormonally active 
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polypeptides consisting of two 1ZkDa chains link- 
ed by disulfide bonds [9,10]. Because of its abun- 
dance in platelets, bone and developing tissues 
[l 11, TGF-fl is likely to function in a broad range 
of processes involved in tissue development and 
repair. 
Using two Mabs, one (IST-4) specific for all FN 
isoforms (tFN) and another (IST-9) specific only 
for ED-A (fig. 1) containing FN molecules (A-FN), 
we have studied whether dexamethasone and TGF- 
,f3 may preferentially induce the expression of the 
ED-A containing FN isoforms. The results 
demonstrate that while dexamethasone does not 
change the ratio between tFN and A-FN, TGF-fl 
preferentially increases the expression of the FN 
isoforms containing the ED-A sequence. 
2. MATERIALS AND METHODS 
Cultured normal human fibroblasts from adult human skin 
(GM-3440) were grown in Eagle’s minimum essential medium 
(MEM) supplemented with 10% FN-free fetal calf serum (FCS) 
(Flow Laboratories, Irvine, Scotland) as reported [12]. 
Cells were grown to confluence in 35mm wells, then the 
medium was replaced with 3.5 ml MEM supplemented with 
0.5% FCS. After 3 days different sets of cells were treated for 
4 days with low-serum medium containing: (i) 450 pM human 
42 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/88/$3.50 0 1988 Federation of European Biochemical Societies 
Volume 228, number 1 
MONOCLONALS : 
FEBS LETTERS February 1988 
IBT-9 
I 
DOMAIN: 
INTERACTIONS : 
--UI 
1 2 3 4 “-11 5 6 
HEPARIN GELATIN HEPARIN CELL HEPARIN FIBRIN 
DNA DNA HEPARIN DNA 
FIBRIN DNA 
Fig. 1. Schematic representation of the structure of a subunbit of human FN. ED-A, ED-B and IIICS represent the three known regions 
of variability due to alternative splicing of mRNA precursors. The sites of specificity of the two Mabs used are indicated. The three 
types of internal homology are also depicted. Arrowheads indicate the sites sensitive to the proteolytic enzyme thermolysin. 
platelet-derived TGF-6 (R and S Systems, Minneapolis, MN); 
(ii) 10 pM dexamethasone (Sigma, St. Louis, MO) and (iii) 
respective solvents. Cell counting after this treatment showed 
that each well contained between 350000 and 400000 cells 
without significant variations among the different sets. After 
this treatment media were quantitatively collected from each 
well, 350~1 of a 10x sample buffer for SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) (100 mM Tris-HCl, pH 6.8, 10% 
SDS, 20% mercaptoethanol, 50% glycerol) was added. To 
estimate the total level of FN in the cultures (FN in media + 
FN in the extracellular matrix), cultures were solubilized by 
directly adding 350~1 of 10 x sample buffer for SDS-PAGE. 80 
~1 of samples prepared in this way were directly analyzed on a 
4-18% SDS-PAGE gradient followed by immunoblotting. All 
experiments were carried out in triplicate. SDS-PAGE and im- 
munoblotting were carried out as in [15]. 
Mabs IST-4 and IST-9 respectively specific for all FN isomers 
(IST-4) and for ED-A sequence (IST-9) were prepared and 
characterized as in (14-161. Densitometric scanning of im- 
munoblots was carried out as in [12]. 
Table 1 
Areas (cm2) of FN peaks from densitometric scanning of im- 
munoblots using the Mabs IST-4 and IST-9a 
Media Total extractsb 
IST-4 IST-9 IST-9 IST-4 IST-9 IST-9 
Controls 1.29 0.345 0.27 1.39 0.365 0.26 
Dexamethasone 2.03 0.4 0.20 2.01 0.43 0.21 
TQFB 1.87 0.8 0.43 3.35 1.82 0.54 
a Values represent the average of three independent ex- 
periments. For experimental procedures see section 2 
b Total extracts: FN in cells plus FN released into the media 
3. RESULTS 
Fig.1 shows a schematic representation of the 
domain structure of human FN and the localiza- 
tion within the molecule of the epitopes recognized 
by the two Mabs used, IST4 and IST-9. IST-4 
recognizes all different FN isoforms (total 
FN = tFN) while IST-9 recognizes only FN 
molecules containing the ED-A sequence (A-FN). 
In order to establish whether treatment of normal 
human fibroblasts by TGF-P dexamethasone 
(which both increase the level of tFN) may increase 
specifically one FN isoform, we have treated 
cultures for 4 days with TGF-,O and dex- 
amethasone. Using the above-mentioned Mabs we 
have studied the relative amounts of tFN and A- 
FN in total extracts and in the media of controls, 
TGF-P-treated cells and dexamethasone-treated 
cells by quantitative densitometric scanning of im- 
munoblots. The results are summarized in table 1. 
Fig.2 shows a typical pattern of gel and im- 
munoblots of the total extracts stained with IST-9 
and IST-4. The results indicate that both dex- 
amethasone and TGF-P treatments increase the 
tFN in total extracts about 2-3-fold, as previously 
reported [7,8]. The increase of tFN in conditioned 
media is almost identical in both dexamethasone- 
and TGF-P-treated cells (see table 1). However, 
while dexamethasone induces a very low increase 
in A’-FN in both media and total extracts, TGF-fl 
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Fig.2. (A) 4-18% gradient SDS-PAGE of total extracts of 
GM-3440 normal human cells: control (lane 1), treated with 
dexamethasone (lane 2). and treated with TGF-fl (lane 3). The 
detailed procedure is described in section 2. The values on the 
left are the molecular masses (in kDa) of the standards (S). 
(B,C) Immunoblot analysis of a 4-18% SDS-PAGE as in (A) 
using Mabs PST-4 (B) and IST-9 (C). The values between (B) 
and (C) are the molecular masses (in kDa) of the standards. 
increases A-FN more than 2-fold in media and 
5-fold in total extracts (see table 1). 
4. DISCUSSION 
Expression of the ED-A sequence in FN has 
been shown to be tissue-specific. The ED-A se- 
quence is absent in the FN mRNA of liver [ 171 
which is the source of plasma FN [ 181. Using a rab- 
bit antiserum to the rat .ED-A sequence, Paul et al. 
[19] demonstrated that this sequence was not pre- 
sent in plasma FN but was expressed in FN re- 
leased by cultured fibroblasts and in FN from 
blood platelets. More recently Borsi et al. [ 151 
demonstrated that in FM from the tissue culture 
medium of tumor-derived human cells the percen- 
tage of A-FN is about IO-times higher than in FN 
released by normal human fibroblasts. Similar 
results were obtained for the other two sites of 
alternative splicing, ED-B [ 161 and IIICS [12]. 
Here we report that while both dexamethasone 
and TGF+ are able to increase the accumulation 
of tFN in normal human fibroblasts, dex- 
amethasone does not change the ratio A-FN/tFN 
while TGF-fl dramatically increases this ratio since 
it preferentially augments the level of the A-FN 
(see table 1). 
This increased accumulation of A-FN induced 
by TGF-fl in normal human fibroblasts could be 
mediated by (i) differential changes in the rate of 
synthesis and/or stability of the various FN 
isoforms, (ii) preferential accumulation in the 
cytoplasm of ED-A containing FN mRNA either 
due to differential stability of the various FN 
mRNAs or to modification in the mechanisms 
regulating RNA splicing. At present studies are 
underway to establish at which level TGF-6 acts. 
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